Sun Pharma Advanced Research Co. commits $10 million to drug development

Sun Pharma Advanced Research Co. commits $10 million to drug development

The School of Medicine is joining with Sun Pharma Advanced Research Co. (SPARC) to support new drug development through the university’s Center for Drug Discovery and the Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship. SPARC will provide $10 million to fund the Skandalaris Center’s LEAP Inventor Challenge and provide drug development expertise to researchers pursuing the commercialization of new pharmaceuticals.
Viruses exacerbate disease caused by Leishmania parasite

Viruses exacerbate disease caused by Leishmania parasite

Washington University School of Medicine’s Stephen Beverley found that viruses hidden inside the parasite Leishmania worsen disease caused by the parasite. Now, an evolutionary survey of the viruses in related parasites suggests that Leishmania’s viruses may have helped it make the jump from infecting insects to infecting vertebrates.
Older Stories